The pharma industry has barely had time to lick its wounds from enhanced Medicaid rebates being included in the just-passed COVID relief bill, and now it faces the prospect of more of the same: popular legislation that incorporates price controls.
House Speaker Nancy Pelosi delivered the bad news during a 23 March press briefing: HR3 could be part of a...






